CELC

Celcuity Announces Launch of Follow-on Offering

Celcuity Announces Appointment of Dr. Igor Gorbatchevsky as VP of Clinical Development and Jill Krause as VP of Clinical Operations

Celcuity Inc. Schedules Release of First Quarter 2021 Financial Results and Webcast

Celcuity, Inc. (CELC) is on the Move, Here's Why the Trend Could be Sustainable

Celcuity's (CELC) Shares March Higher, Can It Continue?

Celcuity Presents Data at AACR Annual Meeting Assessing Gedatolisib, a pan-PI3K/mTOR Inhibitor, in HER2-negative Breast and Ovarian Cancer Patient Tumors with Hyperactive RAS Network Signaling